Phase II trial of combination pembrolizumab, olaparib, and temozolomide for patients with recurrent glioma

被引：0
|
作者：
Schaff, Lauren [1 ]
Fortunato, John [1 ]
Grommes, Christian [1 ]
Gavrilovic, Igor T. [1 ]
Lin, Andrew [1 ]
Pentsova, Elena [1 ]
Miller, Alex [1 ]
Newton, Adam [1 ]
Gonzalez, Ashley [1 ]
Mellinghoff, Ingo K. [1 ]
Kaley, Thomas Joseph [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2087
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RESULTS OF SAFETY LEAD IN OF PHASE II TRIAL OF COMBINATION OLAPARIB, TEMOZOLOMIDE, AND PEMBROLIZUMAB FOR PATIENTS WITH IDH-MUTANT GLIOMA
    Fortunato, John
    Newton, Adam
    Gonzalez, Ashley
    Gavrilovic, Igor
    Miller, Alexandra
    Grommes, Christian
    Lin, Andrew
    Pentsova, Elena
    Mellinghoff, Ingo
    Kaley, Thomas
    Schaff, Lauren
    NEURO-ONCOLOGY, 2023, 25
  • [2] Phase II trial of olaparib in combination with ceralasertib in patients with recurrent osteosarcoma.
    Forrest, Suzanne J.
    Kinnaman, Michael D.
    Livingston, J. Andrew
    Vo, Kieuhoa Tran
    Merriam, Priscilla
    Clinton, Catherine
    Desmith, Kylene
    Cavanaugh, Kerri
    Felicetti, Brunella
    Smith, Simon
    Dean, Emma
    Kao, Pei-Chi
    London, Wendy B.
    Sweet-Cordero, E. Alejandro
    Janeway, Katherine A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients
    Silvani, A
    Eoli, M
    Salmaggi, A
    Lamperti, E
    Maccagnano, E
    Broggi, G
    Boiardi, A
    JOURNAL OF NEURO-ONCOLOGY, 2004, 66 (1-2) : 203 - 208
  • [4] Phase II Trial of Cisplatin Plus Temozolomide, in Recurrent and Progressive Malignant Glioma Patients
    Antonio Silvani
    Marica Eoli
    Andrea Salmaggi
    Elena Lamperti
    Elio Maccagnano
    Giovanni Broggi
    Amerigo Boiardi
    Journal of Neuro-Oncology, 2004, 66 : 203 - 208
  • [5] Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Omuro, Antonio
    Chan, Timothy A.
    Abrey, Lauren E.
    Khasraw, Mustafa
    Reiner, Anne S.
    Kaley, Thomas J.
    DeAngelis, Lisa M.
    Lassman, Andrew B.
    Nolan, Craig P.
    Gavrilovic, Igor T.
    Hormigo, Adilia
    Salvant, Cynthia
    Heguy, Adriana
    Kaufman, Andrew
    Huse, Jason T.
    Panageas, Katherine S.
    Hottinger, Andreas F.
    Mellinghoff, Ingo
    NEURO-ONCOLOGY, 2013, 15 (02) : 242 - 250
  • [6] PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA
    Ney, Douglas
    Deangelis, Lisa
    Nolan, Craig
    Gavrilovic, Igor
    Hormigo, Adilia
    Lassman, Andrew
    Abrey, Lauren
    NEURO-ONCOLOGY, 2008, 10 (05) : 831 - 831
  • [7] Phase II trial of temozolomide in children with recurrent high-grade glioma
    A. Ruggiero
    G. Cefalo
    M.L. Garré
    M. Massimino
    C. Colosimo
    G. Attinà
    I. Lazzareschi
    P. Maurizi
    V. Ridola
    G. Mazzarella
    M. Caldarelli
    C. Di Rocco
    E. Madon
    M.E. Abate
    A. Clerico
    A. Sandri
    R. Riccardi
    Journal of Neuro-Oncology, 2006, 77 : 89 - 94
  • [8] Phase II trial of temozolomide in children with recurrent high-grade glioma
    Ruggiero, A.
    Cefalo, G.
    Garre, M. L.
    Massimino, M.
    Colosimo, C.
    Attina, G.
    Lazzareschi, I.
    Maurizi, P.
    Ridola, V.
    Mazzarella, G.
    Caldarelli, M.
    Di Rocco, C.
    Madon, E.
    Abate, M. E.
    Clerico, A.
    Sandri, A.
    Riccardi, R.
    JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (01) : 89 - 94
  • [9] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [10] Phase II study of combination pembrolizumab and olaparib in patients with advanced cholangiocarcinoma: Interim results
    Yin, Chao
    Armstrong, Samantha Ann
    Agarwal, Seema
    Wang, Hongkun
    Noel, Marcus Smith
    Weinberg, Benjamin Adam
    Marshall, John
    He, Aiwu Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
12345